Abstract
Introduction: Breast cancer is the transformation of healthy breast cells into malignant cells. The disease is characterized by metastases that can range from limited bone metastases to wide-spread and life-threatening metastases. The main goal of caring for these patients is to successfully control the symptoms of the disease, the side effects of the tumor while preserving the quality of life and surviving as long as possible. Objective was to show the specifics of interventions in the health care of a patient with breast cancer with metastatic changes in the endocranium Methods: We used a descriptive method and a conservative direct method: case study of a patient with breast cancer and metastatic changes in the brain according to the method of the Nursing Care Process (NCP). Discussion: Modern nursing care implies patient care according to a scientifically based method, universal in the nursing practice NCP, according to which care is focused on the patient/family, re-specting their preferences. NCP includes: continuous assessment of the patient's condition and defining problems and care needs, setting goals and selecting optimal care strategies. The most COM-mon collaborative problems for our patient were: pain, fatigue, anemia, insomnia. The problems that the nurses solved through independent interventions were: deficit in self-care, prevention of falls and injuries, lack of knowledge regarding the radiation pro-cedure, risk of infection, and the possibility of excess fluid volume. Conclusion: Patients with advanced breast cancer and their families have complex needs, the failure of which can result in impaired quality of life. An individual approach is needed in as-sessing the patient's condition, identifying needs, and planning interventions based on scientific evidence, available health re-sources, and preferences of patient/family. Patient care according to the NCP method promises a more comprehensive approach, improved patient experience as well as improved medical out-comes.
Publisher
Centre for Evaluation in Education and Science (CEON/CEES)
Reference22 articles.
1. Milosavljević Kostić M. Interna medicina. Beograd: Visoka zdravstvena škola strukovnih studija, 2017;
2. Mariotto AB, Etzioni R, Hurlbert M, Penberthy L, Mayer M. Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States. Cancer Epidemiol Biomarkers Prev. 2017;26(6):809-15;
3. Thrift-Perry M, Cabanes A, Cardoso F, Hunt KM, Cruz TA, Faircloth K. Global analysis of metastatic breast cancer policy gaps and advocacy efforts across the patient journey. Breast. 2018;41:93-106;
4. Bošković S. Zdravstvena nega u onkologiji. Beograd: Visoka zdravstvena škola strukovnih studija, 2012; str. 166;
5. Swain SM, Baselga J, Miles D, et al. Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA. Ann Oncol. 2014;25(6):1116-21;